Clearside Biomedical (CLSD) Tops Q4 EPS by 15c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/1/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts CLSD Hot Sheet
Join SI Premium – FREE
Clearside Biomedical (NASDAQ: CLSD) reported Q4 EPS of $0.31, $0.15 better than the analyst estimate of $0.16. Revenue for the quarter came in at $25.7 million versus the consensus estimate of $17.8 million.
For earnings history and earnings-related data on Clearside Biomedical (CLSD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercose ISI downgrades Reddit, says monetization may not offset traffic weakness
- Oppenheimer Holdings (OPY) Reports Q3 EPS of $1.81
- New Break Resources plans $550,000 flow-through share offering
Create E-mail Alert Related Categories
Earnings, Momentum MoversRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
